Ireland· IE-PA-PA1142/016/001
Fucithalmic 10 mg/g Viscous Eye Drops, suspension
A fusidic acid product containing fusidic acid hemihydrate, registered in Ireland by Amdipharm Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fusidic acid is registered in 10 of 19 countries.
Countries holding a registration under ATC S01AA13 (fusidic acid), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Fusidic acid · ATC S01AA13
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Fusidic acid hemihydrate
- Manufacturer
- Amdipharm Limited
- Country
- Ireland (IE)
- ATC code
- S01AA13
- ATC class
- Fusidic acid
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1142/016/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fusidic acid in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFucithalmicAmdipharm Limited
- NorwayFucithalmicAmdipharm Limited
- CzechiaFUCITHALMICAMDIPHARM LIMITED, Dublin
- BelgiumAffusine 20 mg/gWill Pharma
- GermanyFucidineLeo Pharma A/S
- SwedenFucithalmic 1 % ÖgonsalvaAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Фуситалмик
- Germany · Fucithalmic
- Greece · Fusidic Αcid Promopharma
- Italy · Fucithalmic
- Malta · Fucithalmic
- Norway · Fucithalmic
- Poland · Fusacid
- Romania · Fucithalmic
- Sweden · Fucithalmic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a142284b-015f-4eed-8f4b-e33cc41884c7 GET /v1/drugs/a142284b-015f-4eed-8f4b-e33cc41884c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, suspension",
"routes": [
"Ocular use"
],
"source": "hpra",
"atc_all": [
"S01AA",
"S01AA13"
],
"strength": null,
"pa_number": "PA1142/016/001",
"substances": [
"Fusidic acid hemihydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "06/04/1988",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fusidic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.